Wave Life Sciences, Inc. (WVE)
3.78
-0.18
(-4.55%)
USD |
NASDAQ |
Sep 25, 16:00
3.765
-0.02
(-0.40%)
After-Hours: 19:59
Wave Life Sciences Market Cap : 730.59M for Sept. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 25, 2026 | 730.59M |
| September 24, 2026 | 765.38M |
| September 23, 2026 | 763.45M |
| September 22, 2026 | 840.76M |
| September 21, 2026 | 822.40M |
| September 18, 2026 | 840.76M |
| September 17, 2026 | 858.15M |
| September 16, 2026 | 870.72M |
| September 15, 2026 | 862.02M |
| September 14, 2026 | 885.21M |
| September 11, 2026 | 887.14M |
| September 10, 2026 | 902.61M |
| September 09, 2026 | 929.67M |
| September 08, 2026 | 948.99M |
| September 04, 2026 | 939.33M |
| September 03, 2026 | 908.40M |
| September 02, 2026 | 943.19M |
| September 01, 2026 | 960.59M |
| August 31, 2026 | 947.06M |
| August 28, 2026 | 974.12M |
| August 27, 2026 | 997.31M |
| August 26, 2026 | 1.011B |
| August 25, 2026 | 1.015B |
| August 24, 2026 | 989.58M |
| August 21, 2026 | 1.022B |
| Date | Value |
|---|---|
| August 20, 2026 | 1.015B |
| August 19, 2026 | 1.047B |
| August 18, 2026 | 1.022B |
| August 17, 2026 | 983.78M |
| August 14, 2026 | 1.046B |
| August 13, 2026 | 1.005B |
| August 12, 2026 | 1.013B |
| August 11, 2026 | 975.09M |
| August 10, 2026 | 1.173B |
| August 07, 2026 | 1.179B |
| August 06, 2026 | 1.164B |
| August 05, 2026 | 1.146B |
| August 04, 2026 | 1.160B |
| August 03, 2026 | 1.109B |
| July 31, 2026 | 1.065B |
| July 30, 2026 | 1.113B |
| July 29, 2026 | 1.123B |
| July 28, 2026 | 1.138B |
| July 27, 2026 | 1.144B |
| July 24, 2026 | 1.117B |
| July 23, 2026 | 1.112B |
| July 22, 2026 | 1.104B |
| July 21, 2026 | 1.114B |
| July 20, 2026 | 1.102B |
| July 17, 2026 | 1.119B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Filana Therapeutics, Inc. | 36.14M |
| CorMedix, Inc. | 609.69M |
| Eloxx Pharmaceuticals, Inc. | 60.67M |
| Breakthrough Chemistry, Inc. | 0.9243M |
| BioStem Technologies, Inc. | 73.78M |
Market Cap Related Metrics
| PS Ratio | 10.87 |
| PEG Ratio | -0.16 |
| Price to Book Value | 1.611 |
| Price | 3.78 |
| Earnings Yield | -28.74% |
| PEGY Ratio | -0.16 |